NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity

Cancer Biology & Medicine · Published 2026-07-01 · DOI 10.20892/j.issn.2095-3941.2026.0202

Free full text

Authors (3)

Jovanka Gencel-Augusto, Daniel E. Johnson, Jennifer R. Grandis

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gencel-Augusto, J., Johnson, D., Grandis, J. (2026). NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity. Cancer Biology & Medicine. https://doi.org/10.20892/j.issn.2095-3941.2026.0202

Related articles

• Click chemistry-driven tumor theranostics: recent advances, challenges, and future perspectives · Cancer Biology & Medicine · 2026 · Same journal
• Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors · Cancer Biology & Medicine · 2026 · Same journal
• Artificial intelligence empowering precision diagnosis and treatment of breast cancer: advancing global clinical practice with regional insights · Cancer Biology & Medicine · 2026 · Same journal
• Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer · Cancer Biology & Medicine · 2026 · Same journal
• Anogenital human papillomavirus infection patterns by anatomical site and sexual orientation in Chinese men: a national multi-center study · Cancer Biology & Medicine · 2026 · Same journal
• Enhancing FIT-based colorectal cancer screening through risk prediction: a comparative evaluation of 17 models in a large Chinese cohort · Cancer Biology & Medicine · 2026 · Same journal
• Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study · Cancer Biology & Medicine · 2026 · Same journal
• A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer · Cancer Biology & Medicine · 2026 · Same journal
• Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study · Cancer Biology & Medicine · 2026 · Same journal
• Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation · Cancer Biology & Medicine · 2026 · Same journal